Skip to main content
. 2018 Aug 14;9:310. doi: 10.3389/fgene.2018.00310

FIGURE 2.

FIGURE 2

Panel (A) shows the amount of dysregulated miRNAs in the comparison between the neuromuscular junctions and the control blood samples. Panel (B) shows the amount of dysregulated miRNAs in the comparison between the blood samples from ALS affected patients and the neuromuscular junctions. Panel (C) shows the amount of dysregulated miRNAs in the comparison between the blood samples from ALS affected patients and the control. Panel (D) shows the Venn diagram of dysregulated miRNAs in all the three comparisons.